AMGN vs INDB · P/E 24, rev $36.75B vs P/E 16, $3.84B cap
Amgen Inc (AMGN) versus Independent Bank (INDB) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Independent Bank (INDB) is a banks - regional company listed on US.
Latest reported AMGN revenue for 2025-12-31 was $36.75B. Net income was $7.71B. Revenue was up 10.0% from 2024-12-31 to 2025-12-31. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
INDB does not have a complete income-statement cache yet.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. INDB currently screens at market cap $3.84B and trailing P/E 15.8.
Not investment advice. Open the AMGN and INDB stock pages for the full models.
Not investment advice.